purchased from Sigma. Dialysis membranes (molecular weight cut-off (MWCO): 8000-14,000 Da) were obtained from Solarbio Science & Technology Co., Ltd The centrifuge filters (Amicon Ultra-15, MWCO 30,000 Da) were purchased from Millipore Corporation. Deionized water (DIW) was purified using a Millipore water purification system to give a minimum resistivity of 18.2 MΩ•cm. All the other chemicals were purchased from Shanghai Chemical Reagent Co. and used without further purification, unless otherwise specified. Female BALB/c mice were purchased from Nanjing Peng Sheng Biological Technology Co. Ltd. and used under protocols approved by the Soochow University Laboratory Animal Center. All experiments were performed in compliance with the relevant laws and the guidelines of Soochow University Laboratory Animal Center. The Center has approved the experiments.
Matrix-assisted laser desorption ionization spectroscopy (MALDI-TOF).
MALDI-TOF spectra were collected using a Bruker Daltonics
Ultraflextreme mass spectrometer equipped with a Nd:YAG laser (355 nm) in positive linear mode operated with Flex-Control 3.4 software. Protein samples were prepared by using sinapic acid (SA) as matrix.
Molecular docking
Docking calculations were also performed by means of Autodock Vina to investigate the binding mode between the peptide composed of 6 amino acids (ARMAPE) and tPA. In order to match our experiment, we added a handle of 1 unit and 2 units of OEGMA monomer to the head of the peptide, respectively. The structure of tPA is the 2.9 Å resolution in complex with a substrate (2,7-BIS-(4-amidinobenzylidene)-cycloheptan-1 -one) with accession code 1A5H in the Protein Data Bank (PDB) (http://www.rcsb.org). Default parameters were used as described in the AutoDock manual unless otherwise specified.
Preparation of peptide-modified surface and protein adsorption
The poly(HEMA) grafted PU surface was prepared by the method previously reported. tPA, plasminogen, fibrinogen and HSA were labeled with 125 I using previous method. 2 Surfaces were incubated with the protein solution for 3 h at room temperature, rinsed three times with PBS, wicked onto filter paper and transferred to clean tubes for radioactivity determination.
Protein adsorption was expressed as mass per unit surface area (ng/cm 2 ).
Fig. S1
Amounts of adsorbed protein on peptide modified surface.
Synthesis of peptide-terminated POEGMA.
The Peptide-functionalized ATRP initiator was synthesized using standard Conjugation between tPA and Pep-POEGMA 0.5 mL fresh prepared tPA solution (1 mg/mL, PBS buffer, pH 7.4) was added to a small plastic vial, followed by the addition of 100 μL
Pep-POEGMA solution (50 mg/mL). The vial was incubated at 37 °C with gentle shaking for 3 h. The conjugates were purified and concentrated by ultrafiltration using a 30 kDa molecular weight cut-off membrane (12,000 rpm, 3 times, 10 min per time) with PBS (pH 7.4).
The collected conjugate was then characterized by aqueous GPC and HPLC.
Conjugate characterization
RP-HPLC was carried out using an Aligent 1200 Series LC system equipped with a C18 column (250 × 4.6mm; 5μm). Solvent A was 0.1%
TFA in water and solvent B was 0.1% TFA in acetonitrile. Samples were eluted using a linear gradient from 15 to 45% B in 30 min at a flow rate of 0.8 mL/min. Sample detection was carried out using a UV detectors connected in series at λ = 280 nm.
Aqueous GPC was performed on a Agilent 1200 HPLC system equipped with a UV detector and a Sepax Zenix SEC-300 column (7.8 × 300 mm column, pore size 300 Å, particle size 3μm) using a 150 mM phosphate buffer at pH = 7.0 as the mobile phase at 25 °C (flow rate: 1.0 mL/min).
Enzymatic activity assays.
Plasminogen activation by tPA was determined according to a previously published method by monitoring the rate of plasmin production using its specific chromogenic substrate S-2251. 
In vivo pharmacokinetic study
Both free tPA and tPA/Pep-POEGMA conjugate were diluted with TBS (pH 7.4) and calculated amount of each formulation equivalent to 6500 IU/kg were slowly administered for about 10 s via tail vein of the mice.
After dosing, 0.5 mL blood was withdrawn at 1, 5, 10, 15, 30 min and 1 h, respectively. Blood samples were collected into micro-centrifuge tube containing 13 mM sodium citrate to prevent blood coagulation and centrifuged at 4000 rpm for 10 min to separate plasma from other blood elements. The remaining activity of tPA was determined in the same way of the previous method. 
